U.S. Diabetic Foot Ulcer Treatment Market Revenue to Attain USD 5.78 Bn by 2033

18 Dec 2024

Share :

Table of Content

1. U.S. Diabetic Foot Ulcer Treatment Market Revenue and Trends 2023 to 2033 2. Market Overview 3. Report Highlights of the U.S. Diabetic Foot Ulcer Treatment Market  4. Major Trends in the U.S. Diabetic Foot Ulcer Treatment Market  5. U.S. Diabetic Foot Ulcer Treatment Market Coverage 6. Market News  7. U.S. Diabetic Foot Ulcer Treatment Market Companies

U.S. Diabetic Foot Ulcer Treatment Market Revenue and Trends 2023 to 2033

The U.S. diabetic foot ulcer treatment market revenue surpassed USD 3.45 billion in 2024 and is predicted to attain around USD 5.78 billion by 2033, growing at a CAGR of 6.05%.

Market Overview

Diabetic foot ulcer (DFU) is a wound or sore that primarily affects the big toes and the balls of the feet. This ulcer develops as a result of neuropathic and vascular complications commonly seen in individuals with diabetes. Neuropathy leads to a loss of sensation in the feet, making it difficult for patients to notice small injuries or pressure sores. At the same time, vascular complications can impede blood circulation, hindering the healing process and increasing the risk of infection. DFUs typically occur when skin tissue breaks down, resulting in an open sore that exposes the underlying layers of skin and, in some cases, even deeper tissues. This condition can affect anyone diagnosed with diabetes, regardless of age or the type of diabetes they have. Studies indicate that approximately one-third of individuals with diabetes will experience a diabetic foot ulcer at some point in their lifetime, which underscores the importance of regular foot care and monitoring. Treatment for DFUs is multifaceted and depends on the severity of the ulcer. Patients are often advised to wear specially designed footwear that provides better support and minimizes pressure on the affected areas. In some instances, the use of braces, specialized castings, or mobility aids such as wheelchairs or crutches may also be recommended to relieve pressure and promote healing.

The U.S. diabetic foot ulcer treatment market is experiencing significant growth due to the increasing prevalence of diabetes. To facilitate recovery, healthcare providers may apply advanced dressings that maintain a moist wound environment, which is essential for healing. Additionally, procedures such as debridement, which involves carefully removing dead skin tissue and any foreign objects that might exacerbate the ulcer, are often necessary. For patients with persistent infection, a combination of antibiotic therapy, antiplatelet agents, and anticlotting medications may be prescribed to combat infection and promote circulation. Furthermore, incorporating physical exercises designed to improve blood flow and enhance foot strength may also be beneficial for the overall management of DFUs. Managing diabetic foot ulcers requires a comprehensive approach that includes prevention, early detection, and a tailored treatment plan to ensure effective healing and minimize complications. Regular consultations with healthcare professionals are crucial for maintaining foot health in diabetic patients.

Report Highlights of the U.S. Diabetic Foot Ulcer Treatment Market 

• By type, the dressings segment dominated the market with the largest share in 2023. Wound dressing is the most widely used treatment option for patients suffering from diabetic foot ulcers (DFUs). The initial step in the dressing process involves meticulously cleaning the wound using a saline solution to remove any debris and bacteria, which helps to prevent infection. After cleaning, a topical gel or antibiotic ointment is applied to the wound to promote healing and protect against further infection. Once the product is applied, the area is covered with a clean gauze dressing, which serves several important functions. Dressings not only provide a barrier that protects the wound from external contaminants and physical irritation, but they also create an optimal environment for healing by maintaining moisture levels. This moisture can accelerate the healing process while alleviating pain and discomfort for the patient. Furthermore, wound dressings are generally considered a cost-effective solution for managing DFUs. They are accessible and easy to use, making them a preferred choice among healthcare providers and patients. Their ability to reduce symptoms and enhance protection during healing makes them popular in treating diabetic foot ulcers.  
• By ulcer type, the neuro-ischemic ulcers segment held the largest share of the U.S. diabetic foot ulcer treatment market in 2023. Neuro-ischemic ulcers are characterized by the co-occurrence of peripheral neuropathy and ischemia. Peripheral neuropathy results in a loss of sensation in the nerves, while ischemia refers to a deficiency in blood flow to the affected areas. This combination creates an environment conducive to developing ulcers, particularly at vulnerable locations such as the tips of the toes and underneath excessively thickened toenails. The significance of neuro-ischemic ulcers lies in their severe implications for patients. Not only are these ulcers notoriously difficult to treat, but they also carry a high risk of complications. Moreover, the presence of neuro-ischemic ulcers is associated with increased morbidity and mortality rates, underscoring the critical need for effective management and treatment.  
• By treatment type, the wound care devices segment dominated the U.S. diabetic foot ulcer treatment market in 2023. Wound care devices such as debridement devices, negative pressure wound therapy (NPWT), hyperbaric oxygen therapy, and ultrasound therapy absorb wound exudate. These devices speed up healing, contributing to their increased use.
• By end-user, the hospitals segment dominated the market in 2023. Hospitals offer an extensive array of services that encompass everything from accurate diagnosis to comprehensive treatment options. Equipped with advanced medical instruments and cutting-edge technology, these facilities ensure that patients receive the highest standard of care. The availability of skilled healthcare professionals and specialized equipment makes hospitals a top choice for individuals seeking medical attention and support during their health journeys.

Major Trends in the U.S. Diabetic Foot Ulcer Treatment Market 

• Rising Demand for Glucose Monitoring Devices: Transdermal monitoring devices provide continuous, real-time tracking of blood glucose levels, allowing patients to monitor their condition closely throughout the day. These innovative devices are equipped with advanced sensors that not only measure glucose levels but also send immediate alerts whenever there is a deviation from the target range. By promptly notifying users of high or low glucose levels, these devices empower patients to take timely action, ultimately enhancing their ability to manage and maintain their health more effectively.
• Rising Development of Advanced Insulin Devices: Startups are developing groundbreaking insulin delivery devices, including advanced insulin pens and insulin pumps, which provide several benefits compared to conventional delivery methods. Insulin pens are designed to be more user-friendly, allowing for easier handling and administration. They enhance accuracy in dosing, reducing the chances of insulin overdoses or shortages. They also offer incredible flexibility, enabling users to adjust their doses seamlessly according to their needs throughout the day. This innovative approach is transforming the way individuals manage their diabetes, making the process more efficient and comfortable.
• Need for Artificial Pancreas: The artificial pancreas is a groundbreaking medical device designed to replicate the complex functions of a healthy human pancreas. This technology continuously monitors blood glucose levels in diabetic patients and automatically administers precise amounts of insulin as needed. By using advanced algorithms, the device can adjust insulin delivery based on real-time glucose readings, providing personalized treatment that helps maintain optimal blood sugar levels. This innovative approach significantly reduces the burden of managing diabetes, allowing individuals to achieve better control over their condition and improve their overall quality of life.
• Integration of AI in Diabetes Management: Diabetes management encompasses a comprehensive approach to managing conditions through several key components. It includes meticulous insulin delivery management tailored to individual needs, carefully crafted dietary planning that considers nutritional balance and preferences, and health-related exercises designed to promote overall wellness. Personalized care for people with diabetes ensures that each patient receives targeted support based on their unique circumstances. One of the fundamental tools in this management strategy is continuous glucose monitoring (CGM) platforms. These advanced technologies allow for real-time tracking of blood glucose levels, providing patients with immediate feedback on their condition. With built-in alert systems, CGMs notify users when their blood sugar levels fall outside the desired range, whether too high or too low, enabling prompt action to maintain optimal health.
• Increasing Demand for Advanced Wound Care: Advanced wound care treatment involves the use of modern techniques and medicines, including hydrogels and bioengineered skin substitutes. These provide a moist healing environment that supports tissue regeneration and minimizes pain. They can also promote faster healing and reduce the risk of infections.

U.S. Diabetic Foot Ulcer Treatment Market Coverage

Market News 

• In April 2024, Smith & Nephew announced the launch of RENASYS EDGE Negative Pressure Wound Therapy (NPWT) system in the U.S. for treating chronic wounds.

U.S. Diabetic Foot Ulcer Treatment Market Companies

• ConvaTec Group Plc
• 3M
• B. Braun Melsungen AG
• Medline Industries, Inc.
• Coloplast Group
• Smith & Nephew
• Cardinal Health Inc
• Organogenesis Inc.
• URGO
• Kerecis
• Mölnlycke Health Care AB.
• MiMedx

Market Segmentation

By Type

• Advanced Wound Care
• Biologics
• Dressings

By Ulcer Type

• Neuropathic Ulcers
• Neuro-ischemic Ulcers
• Ischemic Ulcers

By Grade

• Grade 1
• Grade 2
• Grade 3
• Grade 4
• Grade 5

By Treatment Type

• Wound Care Dressings
• Wound Care Devices
• Active Therapies
• Others

By End User

• Hospitals
• Home Care
• Ambulatory Surgical Center

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344